Physiologic Sodium Chloride Solution
Ischemic Disease
Zhujiang HospitalSmall moleculePhase 3Active
B
58/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 43/ 100
- Competitive Position
- 95/ 100
Competitive context
2 Active assets in the Ischemic Disease cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Aspirin Xijing Hospital | Phase 4 | BBB |
Pregabalin Karolinska Institutet | Phase 4 | BB |
Urokinase-Type Plasminogen Activator medac GmbH | Phase 3 | BB |
Vorapaxar Merck Sharp & Dohme LLC | Phase 3 | B |
Tocilizumab Zhujiang Hospital | Phase 3 | B |
View all 9 →
Same molecule, other indications
Physiologic Sodium Chloride Solution is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →